Importantly, high PRKCDBP expression is associated with the transcriptional signature of activated pyroptosis in NSCLC, implying the involvement of PRKCDBP in the anti‐oncogenic activity of pyroptosis. This evidence concerns the gene CAVIN3 and non-small cell lung carcinoma.